Strategic Partnership

PAICON, a global leader in cancer diagnostic AI, and Morphle Labs, an innovator in digital pathology hardware and software, are excited to announce a groundbreaking partnership. Together, they aim to bring diagnostic cancer AI algorithms to the market through Morphle’s advanced scanners and software, offering a comprehensive and integrated solution for oncopathologists. 

This collaboration merges PAICON’s cutting-edge, unbiased AI algorithms with Morphle’s state-of-the-art diagnostic infrastructure. The partnership addresses critical needs in oncology by providing faster, more accurate, and assisted diagnoses, empowering pathologists to deliver precision care efficiently. 

The Integrated Solution

By combining PAICON’s robust AI models with Morphle’s digital pathology scanners and software, this partnership delivers a seamless workflow for oncopathologists. From the digitization of histopathology slides—a critical pain point for many labs—to providing cutting-edge AI-assisted diagnostics, this collaboration bridges gaps in the diagnostic workflow.

This integrated solution: 

• Accelerates diagnostic processes, enabling faster decision-making. 
• Assists pathologists with AI-driven insights to enhance diagnostic accuracy. 
• Facilitates early treatment planning, ensuring patients receive the right care at the right time. 

A Step Toward Improved Cancer Care

“Partnering with Morphle Labs allows us to bring our diagnostic AI algorithms to pathologists worldwide through a reliable and innovative platform,” said  Dr. Manasi A-Ratnaparkhe CEO of PAICON. “Together, we’re not just enhancing diagnostic workflows—we’re helping patients get faster and more precise care, improving outcomes on a global scale.” 

Morphle Labs’ CEO,  Rohit Hiwale echoed this sentiment: “Our scanners and software are designed to redefine pathology workflows, and integrating PAICON’s AI solutions takes this mission to the next level. This partnership ensures oncopathologists have access to the tools they need for rapid, reliable diagnoses.” 

Global Impact on Oncology Diagnostics

This partnership signifies a significant advancement in oncology diagnostics, combining data diversity, AI innovation, and cutting-edge technology. By addressing diagnostic challenges and optimizing workflows, PAICON and Morphle Labs are setting a new standard for precision cancer care. 

For more information about this partnership, visit www.paicon.com and www.morphlelabs.com.